BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 23399423)

  • 1. Decline in influenza vaccine effectiveness with time after vaccination, Navarre, Spain, season 2011/12.
    Castilla J; Martínez-Baz I; Martínez-Artola V; Reina G; Pozo F; García Cenoz M; Guevara M; Morán J; Irisarri F; Arriazu M; Albéniz E; Ezpeleta C; Barricarte A; ;
    Euro Surveill; 2013 Jan; 18(5):. PubMed ID: 23399423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine effectiveness in preventing laboratory-confirmed influenza in Navarre, Spain: 2013/14 mid-season analysis.
    Castilla J; Martínez-Baz I; Navascués A; Fernandez-Alonso M; Reina G; Guevara M; Chamorro J; Ortega MT; Albéniz E; Pozo F; Ezpeleta C; ;
    Euro Surveill; 2014 Feb; 19(6):. PubMed ID: 24556347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of seasonal 2012/13 vaccine in preventing laboratory-confirmed influenza infection in primary care in the United Kingdom: mid-season analysis 2012/13.
    McMenamin J; Andrews N; Robertson C; Fleming D; Durnall H; von Wissmann B; Ellis J; Lackenby A; Cottrell S; Smyth B; Zambon M; Moore C; Watson J; Pebody R
    Euro Surveill; 2013 Jan; 18(5):. PubMed ID: 23399421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of influenza vaccine against laboratory-confirmed influenza, in the late 2011-2012 season in Spain, among population targeted for vaccination.
    Jiménez-Jorge S; de Mateo S; Delgado-Sanz C; Pozo F; Casas I; Garcia-Cenoz M; Castilla J; Pérez E; Gallardo V; Rodriguez C; Vega T; Quiñones C; Martínez E; Vanrell JM; Giménez J; Castrillejo D; Serrano Mdel C; Ramos JM; Larrauri A;
    BMC Infect Dis; 2013 Sep; 13():441. PubMed ID: 24053661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study.
    Kissling E; Valenciano M; Larrauri A; Oroszi B; Cohen JM; Nunes B; Pitigoi D; Rizzo C; Rebolledo J; Paradowska-Stankiewicz I; Jiménez-Jorge S; Horváth JK; Daviaud I; Guiomar R; Necula G; Bella A; O'Donnell J; Głuchowska M; Ciancio BC; Nicoll A; Moren A
    Euro Surveill; 2013 Jan; 18(5):. PubMed ID: 23399425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza vaccine effectiveness in preventing inpatient and outpatient cases in a season dominated by vaccine-matched influenza B virus.
    Martínez-Baz I; Navascués A; Pozo F; Chamorro J; Albeniz E; Casado I; Reina G; Cenoz MG; Ezpeleta C; Castilla J;
    Hum Vaccin Immunother; 2015; 11(7):1626-33. PubMed ID: 25996366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of previous episodes of influenza and vaccination in preventing laboratory-confirmed influenza in Navarre, Spain, 2013/14 season.
    Castilla J; Navascués A; Fernández-Alonso M; Reina G; Albéniz E; Pozo F; Álvarez N; Martínez-Baz I; Guevara M; García-Cenoz M; Irisarri F; Casado I; Ezpeleta C;
    Euro Surveill; 2016 Jun; 20(22):. PubMed ID: 27277013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trivalent inactivated seasonal influenza vaccine effectiveness for the prevention of laboratory-confirmed influenza in a Scottish population 2000 to 2009.
    Simpson CR; Lone NI; Kavanagh K; Ritchie LD; Robertson C; Sheikh A; McMenamin J
    Euro Surveill; 2015 Feb; 20(8):. PubMed ID: 25742433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher vaccine effectiveness in seasons with predominant circulation of seasonal influenza A(H1N1) than in A(H3N2) seasons: test-negative case-control studies using surveillance data, Spain, 2003-2011.
    Savulescu C; Jiménez-Jorge S; Delgado-Sanz C; de Mateo S; Pozo F; Casas I; Larrauri A;
    Vaccine; 2014 Jul; 32(35):4404-4411. PubMed ID: 24968153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine effectiveness of 2011/12 trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: evidence of waning intra-seasonal protection.
    Pebody R; Andrews N; McMenamin J; Durnall H; Ellis J; Thompson CI; Robertson C; Cottrell S; Smyth B; Zambon M; Moore C; Fleming DM; Watson JM
    Euro Surveill; 2013 Jan; 18(5):. PubMed ID: 23399424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of the trivalent influenza vaccine in Navarre, Spain, 2010-2011: a population-based test-negative case-control study.
    Martínez-Baz I; Martínez-Artola V; Reina G; Guevara M; Cenoz MG; Morán J; Irisarri F; Arriazu M; Albeniz E; Castilla J;
    BMC Public Health; 2013 Mar; 13():191. PubMed ID: 23496887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early estimates of seasonal influenza vaccine effectiveness in Europe among target groups for vaccination: results from the I-MOVE multicentre case-control study, 2011/12.
    Kissling E; Valenciano M;
    Euro Surveill; 2012 Apr; 17(15):. PubMed ID: 22516046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season.
    Belongia EA; Kieke BA; Donahue JG; Greenlee RT; Balish A; Foust A; Lindstrom S; Shay DK;
    J Infect Dis; 2009 Jan; 199(2):159-67. PubMed ID: 19086915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of the 2010-11 seasonal trivalent influenza vaccine in Spain: cycEVA study.
    Jiménez-Jorge S; Savulescu C; Pozo F; de Mateo S; Casas I; Ledesma J; Larrauri A; ;
    Vaccine; 2012 May; 30(24):3595-602. PubMed ID: 22472792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early estimates of influenza vaccine effectiveness in Navarre, Spain: 2012/13 mid-season analysis.
    Castilla J; Martinez-Baz I; Martinez-Artola V; Fernandez-Alonso M; Reina G; Guevara M; Garcia Cenoz M; Elia F; Alvarez N; Barricarte A; Ezpeleta C
    Euro Surveill; 2013 Feb; 18(7):2. PubMed ID: 23449182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.
    Valenciano M; Kissling E; Reuss A; Rizzo C; Gherasim A; Horváth JK; Domegan L; Pitigoi D; Machado A; Paradowska-Stankiewicz IA; Bella A; Larrauri A; Ferenczi A; ; Lazar M; Pechirra P; Korczyńska MR; Pozo F; Moren A;
    Euro Surveill; 2016; 21(7):pii=30139. PubMed ID: 26924024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2012/13 end of season results.
    Andrews N; McMenamin J; Durnall H; Ellis J; Lackenby A; Robertson C; von Wissmann B; Cottrell S; Smyth B; Moore C; Gunson R; Zambon M; Fleming D; Pebody R
    Euro Surveill; 2014 Jul; 19(27):5-13. PubMed ID: 25033051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating influenza vaccine effectiveness in Spain using sentinel surveillance data.
    Jimenez-Jorge S; de Mateo S; Delgado-Sanz C; Pozo F; Casas I; Garcia-Cenoz M; Castilla J; Rodriguez C; Vega T; Quinones C; Martinez E; Vanrell JM; Gimenez J; Castrillejo D; Altzibar JM; Carril F; Ramos JM; Serrano MC; Martinez A; Torner N; Perez E; Gallardo V; Larrauri A;
    Euro Surveill; 2015 Jul; 20(28):. PubMed ID: 26212144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13.
    Kissling E; Valenciano M; Buchholz U; Larrauri A; Cohen JM; Nunes B; Rogalska J; Pitigoi D; Paradowska-Stankiewicz I; Reuss A; Jiménez-Jorge S; Daviaud I; Guiomar R; O'Donnell J; Necula G; Głuchowska M; Moren A
    Euro Surveill; 2014 Feb; 19(6):. PubMed ID: 24556348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of subunit influenza vaccination in the 2014-2015 season and residual effect of split vaccination in previous seasons.
    Castilla J; Navascués A; Fernández-Alonso M; Reina G; Pozo F; Casado I; Guevara M; Martínez-Baz I; Barricarte A; Ezpeleta C; ;
    Vaccine; 2016 Mar; 34(11):1350-7. PubMed ID: 26854911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.